Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,269 | 256 | 99.1% |
| Gift | $40.92 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,242 | 74 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $949.74 | 79 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $364.95 | 18 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $263.04 | 22 | $0 (2023) |
| Merck Sharp & Dohme LLC | $230.06 | 16 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $175.18 | 2 | $0 (2024) |
| Evoke Pharma, Inc. | $174.72 | 5 | $0 (2022) |
| Gilead Sciences, Inc. | $172.97 | 8 | $0 (2023) |
| Ardelyx, Inc. | $122.88 | 7 | $0 (2023) |
| Abbott Laboratories | $108.40 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $362.13 | 12 | REVANCE THERAPEUTICS, INC. ($175.18) |
| 2023 | $1,155 | 76 | ABBVIE INC. ($284.90) |
| 2022 | $1,419 | 81 | ABBVIE INC. ($535.65) |
| 2021 | $1,373 | 89 | AbbVie Inc. ($394.95) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | W. L. Gore & Associates, Inc. | GORE ENFORM Preperitoneal Biomaterial (Device) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Devices | ||||||
| 12/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $144.05 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: GI | ||||||
| 04/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: GI | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 01/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Gastroenterology | ||||||
| 01/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Gastroenterology | ||||||
| 12/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $108.40 | General |
| Category: Diabetes Care | ||||||
| 12/18/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.19 | General |
| 12/14/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $82.92 | General |
| Category: HCV | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Gastroenterology | ||||||
| 11/30/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Gastroenterology | ||||||
| 11/20/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Gastroenterology | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 188 | 197 | $22,041 | $7,494 |
| 2022 | 6 | 372 | 411 | $46,994 | $19,245 |
| 2021 | 9 | 380 | 401 | $52,558 | $21,972 |
| 2020 | 2 | 93 | 96 | $11,859 | $4,334 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 57 | 61 | $7,991 | $3,074 | 38.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 90 | 94 | $7,332 | $2,815 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 23 | $3,013 | $818.37 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 19 | 19 | $3,705 | $785.92 | 21.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 144 | 171 | $22,401 | $9,761 | 43.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 117 | 126 | $9,828 | $3,902 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 46 | $6,026 | $2,642 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $6,045 | $2,058 | 34.0% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 24 | 24 | $1,680 | $443.99 | 26.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $1,014 | $438.98 | 43.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 82 | 89 | $11,659 | $5,230 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 83 | $10,873 | $4,661 | 42.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $7,995 | $2,881 | 36.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 59 | 63 | $4,914 | $2,100 | 42.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $4,725 | $1,993 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 21 | $4,074 | $1,701 | 41.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 47 | 50 | $3,900 | $1,673 | 42.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 17 | 17 | $3,298 | $1,429 | 43.3% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 16 | 16 | $1,120 | $304.35 | 27.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 81 | 84 | $10,923 | $3,980 | 36.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 12 | $936.00 | $354.00 | 37.8% |
About Maribeth Gambill, APN
Maribeth Gambill, APN is a Family healthcare provider based in Bastrop, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144334863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maribeth Gambill, APN has received a total of $4,310 in payments from pharmaceutical and medical device companies, with $362.13 received in 2024. These payments were reported across 258 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,269).
As a Medicare-enrolled provider, Gambill has provided services to 1,033 Medicare beneficiaries, totaling 1,105 services with total Medicare billing of $53,045. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Bastrop, LA
- Active Since 08/18/2006
- Last Updated 05/25/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144334863
Products in Payments
- XIFAXAN (Drug) $773.62
- RINVOQ (Biological) $401.64
- ZENPEP (Drug) $380.39
- HUMIRA (Biological) $333.53
- SKYRIZI (Biological) $235.05
- DIFICID (Drug) $230.06
- DAXXIFY (Drug) $175.18
- GIMOTI (Drug) $174.72
- TRULANCE (Drug) $156.26
- ENTYVIO (Biological) $139.10
- MOTEGRITY (Drug) $123.94
- IBSRELA (Drug) $122.88
- LINZESS (Drug) $115.33
- FREESTYLE LIBRE 3 (Device) $108.40
- CREON (Drug) $94.97
- Epclusa (Drug) $82.92
- Linzess (Drug) $78.81
- DOVATO (Drug) $75.01
- SUTAB (Drug) $64.32
- DUPIXENT (Biological) $64.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bastrop
Mrs. Olivia Blankenship, F.n.p, F.N.P
Family — Payments: $5,212
Sarah Cervantes, Rn, Fnp-C, RN, FNP-C
Family — Payments: $4,871
Jihong Kim, Np, NP
Family — Payments: $2,432
Dr. Sheryl Innerarity, Fnp, Cns, FNP, CNS
Family — Payments: $2,276
Tamatha Hawkins, Np, NP
Family — Payments: $2,218
Jessica Pack, Aprn, APRN
Family — Payments: $1,275